Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/WGS
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

GeneDx Holdings Corp (WGS) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

GeneDx (WGS) trades at $88.4, down slightly by 0.09% on the day, with a neutral technical signal and mixed earnings history. The company reported Q2 2026 revenue of $114.4M, beating estimates, and achieved adjusted profitability ahead of schedule. However, 2026 net income margin is negative at -23.4%, and valuation ratios like EV/EBITDA of 161.17 indicate high expectations. Recent news highlights CEO recognition and partnerships advancing genomic diagnostics.
Outlook is cautiously optimistic with 91% analyst buy ratings but faces risks from sustained losses and high valuation. Investment opportunity lies in genomic growth and operational improvements, while key risks include profitability challenges and competitive pressures. The consensus price target is $79.50, below current price, suggesting limited near-term upside.
Read full analysis

Key Stats

  • Market Cap
    $2.64B
  • Volume
    510,360
  • Sector
    Health
  • 52W High
    $167.51
  • 52W Low
    $34.51
  • Typical Hold Time
    19 Days
  • Enterprise Value
    $2.67B
  • Div Yield
    -
  • Trading Activity
    -
$86.51
52W Low: $34.51
05 May 2026
52W High: $167.51
25 Nov 2025

Track GeneDx Holdings Corp (WGS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, GeneDx Holdings Corp has traded between a low of $34.51 and a high of $167.51, highlighting its annual price range. Buy and sell GeneDx Holdings Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Most Recent News

Content is generated by Aura AI

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals reported a 12% revenue increase to $3.33 billion in Q2, driven by its dominant cystic fibrosis treatments. UBS raised its price target from $585 to $615, reflecting confidence in Vertex's strong financials and growth potential....

Analyst Insights
2 hours ago
Stuart Mooney
Bullish
news icon
Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX, trading near $148 per share with a market cap of about $1.95 trillion, is preparing for Starship's first orbital mission and the deployment of its first operational Starlink V3 satellites. This milestone is key for expanding Starlink's global...

Market News
3 hours ago
Alex Lavoie
Bullish
news icon
SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

Atlas Salt advances Newfoundland mine to supply North America's de-icing salt market with $300M+ financing interest.

Atlas Salt Inc. is progressing with its Great Atlantic Salt Project in Newfoundland, aiming to become North America's first new salt mine in nearly 30 years. Construction is now permanent, and the project has secured financing interest exceeding $300...

Market News
4 hours ago
Newsfile Corp
Bullish
news icon
Atlas Salt advances Newfoundland mine to supply North America's de-icing salt market with $300M+ financing interest.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $2.64B
  • Volume
    510,360
  • Sector
    Health
  • 52W High
    $167.51
  • 52W Low
    $34.51
  • Typical Hold Time
    19 Days
  • Enterprise Value
    $2.67B
  • Div Yield
    -
  • Trading Activity
    -
$86.51
52W Low: $34.51
05 May 2026
52W High: $167.51
25 Nov 2025

Track GeneDx Holdings Corp (WGS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, GeneDx Holdings Corp has traded between a low of $34.51 and a high of $167.51, highlighting its annual price range. Buy and sell GeneDx Holdings Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!